Clinical Trial

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is a Prospective, observational research study for patients with NMOSD under the care of a licensed neurologist. Approximately 800 patients and 35 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-10; most recent amendment 2026-02-05.
Trial Details
NCT Number NCT04886492
Lead Sponsor CorEvitas
Conditions Neuromyelitis Optica Spectrum Disorder
Enrollment 800 participants
Start Date 2021-04-28
Primary Completion 2099-01 (estimated)
Study Completion 2099-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-09